학술논문

A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patients
Document Type
Article
Source
In: Hematological Oncology. (Hematological Oncology, December 2022, 40(5):906-913)
Subject
Language
English
ISSN
10991069
02780232